Dynamic Balancing: DEPTOR Tips the Scales
Author(s) -
Christopher G. Proud
Publication year - 2009
Publication title -
journal of molecular cell biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.825
H-Index - 62
eISSN - 1674-2788
pISSN - 1759-4685
DOI - 10.1093/jmcb/mjp012
Subject(s) - pi3k/akt/mtor pathway , regulator , downstream (manufacturing) , key (lock) , microbiology and biotechnology , biology , master regulator , signal transduction , cancer research , computational biology , genetics , gene , business , ecology , marketing , transcription factor
The mammalian target of rapamycin, mTOR, is a key node in cellular regulation: its dysregulation is important in a number of disease states, including various cancers. A recent study identifies a new partner and regulator of mTOR, which can alter the balance of signaling downstream of mTOR and appears to be important in certain cancers, such as multiple myelomas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom